Bursitis Clinical Trial
Official title:
Steroid Injection for the Treatment of Greater Trochanteric Pain Syndrome: A Randomized Controlled Trial
The objective of this study is to conduct a randomized, single-blinded placebo controlled trial comparing two modalities for the treatment of pain and mobility associated with trochanteric bursitis: (1) injection of glucocorticosteroid and local anesthetic, (2) injection of local anesthetic. We hope to determine whether steroid injections provide a statistically significant improvement in pain symptoms and hip mobility in subjects with trochanteric bursitis, as compared to an injection of local anesthetic. Our null hypothesis is that no statistically significant difference exists between the two treatment modalities.
Trochanteric bursitis is an inflammation of the bursal sac overlying the greater trochanter
of the femur. The etiology of this disease is unknown, but it is clinically characterized by
chronic aching pain over the lateral aspect of the hip, which can be exacerbated by certain
movements such as external rotation and abduction (2). In order to objectively determine the
level of pain and mobility associated with trochanteric bursitis, some orthopaedic surgeons
use scoring systems (a qualitative and quantitative scoring test) to assess patients (4).
In our practice, trochanteric bursitis has been treated by injection of glucocorticosteroids
(steroids) combined with local anesthetic at the site of the greater trochanter (1).
Additionally, it has been found that increasing steroid dosage provides a greater level of
relief (3). Although steroids are usually an effective treatment, no studies to date have
compared steroid injections for relief of trochanteric bursitis pain and mobility versus a
placebo injection or local anesthetic injection alone.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01205477 -
Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment
|
Phase 2 | |
| Terminated |
NCT01807962 -
Local Injection Under US Control in GTPS.
|
Phase 3 | |
| Completed |
NCT01050465 -
MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use
|
N/A | |
| Completed |
NCT02841462 -
Hydrothermal Ablation in Recurrent and Chronic Symptomatic Bursitis
|
N/A | |
| Completed |
NCT00480675 -
Randomized Study Comparing Fluoroscopically-Guided Versus Blinded Trochanteric Bursa Injections
|
N/A | |
| Withdrawn |
NCT00914836 -
Comparison of 2 Doses of Corticosteroid Subacromial Injections for the Treatment of Painful Shoulder
|
N/A | |
| Completed |
NCT00352625 -
Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis
|
Phase 3 | |
| Terminated |
NCT04931511 -
Comparison Between Subacromial Ultrasound Guided and Systemic Steroid Injection for Frozen Shoulder
|
Phase 4 | |
| Completed |
NCT01161615 -
MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder
|
Phase 3 | |
| Terminated |
NCT00426985 -
Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis
|
Phase 3 | |
| Recruiting |
NCT05214547 -
Shockwave Therapy Effectiveness
|
N/A | |
| Completed |
NCT00634608 -
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
|
N/A | |
| Completed |
NCT01506154 -
Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder
|
Phase 3 | |
| Completed |
NCT02221817 -
Comparison of Ultrasound Guided Versus Blind Corticosteroid Injection for Trochanteric Bursitis
|
N/A | |
| Completed |
NCT02126878 -
Comparison of Steroid Dosages on the Efficacy of Trochanteric Bursa Injection
|
N/A |